dysplasia

(redirected from Cervical dysplasia)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to dysplasia

abnormal development (of organs or cells) or an abnormal structure resulting from such growth

References in periodicals archive ?
The primary objectives were to evaluate the antiinflammatory, antimicrobial, and antiviral effects of vitamin D suppositories in women with chronic recurrent cervical infections or cervical dysplasias.
26) progression of cervical dysplasia was observed in 14% of HIV-positive women compared with 7% of HIV-negative women.
2 million women are diagnosed with low-grade cervical dysplasia (CIN 1), 300,000 with high-grade dysplasia (CIN 2/3) and 2.
While some studies have not found an association between condom use and rates of HPV infection, other studies have shown an association between condom use and a reduced likelihood of genital warts and cervical dysplasia as well as a more rapid regression of HPV-related lesions which suggests that consistent condom use does reduce negative outcomes of HPV.
We are alert to trials of HPV vaccines for cervical dysplasia and will monitor the results.
The Institute of Medicine emphasized that data on sexually transmitted infections, Pap smear screening, and cervical dysplasia among lesbians were needed to guide clinical practice, policy development, and patient education.
Formaldehyde-fixed, paraffin embedded cervical tissue samples from 17 age-matched patients who displayed a high-grade cervical dysplasia from northeast North Dakota and north-west Minnesota were used in order to study the presence of HPV serotypes.
Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kelaghan Jet al.
Compliance with Therapy for Cervical Dysplasia Among Women of Low Socioeconomic Status.
included new findings on reducing perinatal transmission, indications that HAART antiretroviral therapy may help improve outcome in cervical dysplasia, and discussion of the serious problem of increased incidence of some drug toxicities in women.
Given that interferons are known immunomodulators, I do not want any of us to have to wait for a retrospective study that may show these drugs to be a risk factor for cervical dysplasia.
ACTG 866 is assessing the effect of the protease inhibitor indinavir on the progression of cervical dysplasia and HPV infections in HIV-infected women, and on the amount of HIV in vaginal secretions.
For example, 11 of the laser-treated women (31 percent) developed cervical dysplasia, compared with five of the women (18 percent) in the observation-only group and six assigned to cryotherapy (11 percent).
It also reviews key players involved in the therapeutic development for Cervical Dysplasia.